Cargando…
Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists
Background: Immune checkpoint inhibitor (ICI)-associated hypothalamic–pituitary–adrenal axis disruption can lead to hypocortisolism. This is a life-threatening but difficult to diagnose condition, due to its non-specific symptoms that overlap with symptoms of malignancy. Currently, there is no conse...
Autores principales: | Druce, Irena, Tawagi, Karine, Shaw, Julie L. V., Ibrahim, Andrea, Lochnan, Heather, Ong, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315594/ https://www.ncbi.nlm.nih.gov/pubmed/35877230 http://dx.doi.org/10.3390/curroncol29070370 |
Ejemplares similares
-
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency
por: Arlt, Wiebke, et al.
Publicado: (2020) -
SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency
management of acute adrenal insufficiency (adrenal crisis) in adult
patients
por: Arlt, Wiebke
Publicado: (2016) -
Neonatal adrenal insufficiency: Turkish Neonatal and Pediatric Endocrinology and Diabetes Societies consensus report
por: Yiğit, Şule, et al.
Publicado: (2018) -
Is this really just “fatigue”? A case series of immune‐related central adrenal insufficiency secondary to immune checkpoint inhibitors
por: Nagasaka, Misako, et al.
Publicado: (2018) -
PSAT042 Adrenal Insufficiency Associated to Immune Checkpoint Inhibitors
por: Barreto, Brigida Colon, et al.
Publicado: (2022)